The pVAXhTPA-BB0405 DNA vaccine was designed as described before in Wagemakers et al.10 (link). In the BB0405 gene sequence of B. burgdorferi B31 (NCBI Reference Sequence: NC_001318.1) the 18aa signal sequence (predicted by SignalP 4.0 web-based software, CBS, Lyngby, Denmark) was replaced with the human tissue plasminogen activator (hTPA) signal sequence (genbank AAA61213.1)26 (link). The resulting sequence was codon-optimized to mouse tRNA usage with Java Codon Adaptation tool (Braunschweig, Germany)27 (link). At the 5′ end a BamH1 and a Kozak sequence were added, and at the 3′ end a sequence encoding a double stop codon and a Xho1 were added. The insert was synthesized (BaseClear, Leiden, The Netherlands) and ligated into a BamH1/Xho1 restricted empty pVAX vector (Invitrogen, Carlsbad, CA, USA). The plasmid was amplified using a Nucleobond Xtra EF kit (Macherey-Nagel, Düren, Germany) and resuspended in DNase free water.
Free full text: Click here